Ambuja Cements Limited (AMBUJACEM) — Financial Results | 31 July 2025(3 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements reported Q1 FY26 standalone revenue of ₹5,520.86 crore and profit after tax of ₹855.49 crore, declining 3.4% and 7.9% respectively from Q4 FY25. The company completed acquisition of 72.66% stake in Orient Cement for ₹5,903.03 crore and owns 99.94% of Penna Cement. The Board approved Shobhit Dwivedi as internal auditor effective October 1, 2025, replacing Mithlesh Satija. Consolidated revenue reached ₹10,244.11 crore with PAT of ₹969.66 crore. Pending CCI litigation includes ₹1,163.91 crore cartelization penalty and ₹29.84 crore collusive bidding penalty under appeal.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Ambuja Cements delivered strong Q1 FY26 results with consolidated revenue of ₹10,289 crores, up 23% YoY, driven by highest-ever cement sales of 18.4 million tonnes (up 20% YoY) and market share gains of 2 percentage points to 15.5%. Operating EBITDA reached ₹1,961 crores, up 53% YoY, with margin expansion of 3.8 percentage points to 19.1%. Profit after tax grew 24% YoY to ₹970 crores. The company approved the amalgamation with Adani Cementation and commissioned 57 MW renewable energy capacity.

3 Financial Results 🔴 High Importance Neutral 📄 PDF

Ambuja Cements Limited submitted an audio recording of its analysts and investors call held on July 31, 2025, discussing unaudited financial results for Q1 FY2026 (quarter ended June 30, 2025). The recording is available on the company's website. This follows the preliminary results announcement from July 18, 2025, providing stakeholders detailed management commentary on standalone and consolidated performance.

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMBUJACEM — Free

Free account · 2 AI queries/day